Aspire Private Capital »

Biondvax Pharmaceuticals shares owned by Aspire Private Capital

Quarter-by-quarter ownership of Biondvax Pharmaceuticals (SCNI) shares owned by Aspire Private Capital from 13F filings

Historical chart of Aspire Private Capital investment in Biondvax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biondvax Pharmaceuticals held by Aspire Private Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biondvax Pharmaceuticals by Aspire Private Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $83 160 0.52
2023-12-31 $95 160 0.59
2023-09-30 $139 160 0.87
2023-06-30 $226 160 1.41
2023-03-31 $346 160 2.16
2022-12-31 $474 160 2.96

More positions owned by Aspire Private Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ssga Active Tr Spdr Ssga Fxd (FISR)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Value Etf (VTV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ssga Active Tr Spdr Ssga Us Sct (XLSR)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Ser Tr Bloomberg High Y (JNK)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Ser Tr Portfolio S&p600 (SPSM)

View all positions for Aspire Private Capital

Top funds holding Biondvax Pharmaceuticals

Armistice Capital
Citadel Advisors
Millennium Management
Rhumbline Advisers
Morgan Stanley
UBS Group
Credit Agricole
Main Street Group
Aspire Private Capital
Global Retirement Partners
Qube Research & Technologies
Royal Bank of Canada

View all funds holding Biondvax Pharmaceuticals